Search Results

Remote microglial activation and the production of proinflammatory cytokines predicts the development of neuropathic pain after spinal cord injury.

• Authors : Detloff MR; Fisher LC; McGaughy V

• Source: Journal of Neurologic Physical Therapy; 2006 Dec, Vol. 30 Issue 4, p202-202, 1p

Record details

Shifting our attention earlier in the multiple sclerosis disease course.

• Authors : Epstein S; Department of Neurology, Yale University, New Haven, Connecticut, USA.; Longbrake EE

• Source: Current opinion in neurology [Curr Opin Neurol] 2024 Mar 29. Date of Electronic Publication: 2024 Mar 29.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9319162 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Choroid plexus volume differentiates MS from its mimics.

• Authors : Levit E; Department of Neurological Sciences, Larner College of Medicine, The University of Vermont, Burlington, VT, USA.; The University of Vermont Medical Center, Burlington, VT, USA.

• Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Mar 13, pp. 13524585241238094. Date of Electronic Publication: 2024 Mar 13.Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

• Authors : Cross AH; Washington University School of Medicine, St Louis, Missouri.; Gelfand JM

• Source: JAMA neurology [JAMA Neurol] 2024 Mar 11. Date of Electronic Publication: 2024 Mar 11.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print-Electronic Cited Medium:

Record details

A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases.

• Authors : Yandamuri SS; Department of Neurology, Yale School of Medicine, New Haven, CT.; Department of Immunobiology, Yale School of Medicine, New Haven, CT.

Subjects: Autoantibodies*/Autoantibodies*/Autoantibodies*/metabolism ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/metabolism; Humans

• Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 Mar 01; Vol. 212 (5), pp. 785-800.Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet

Record details

Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple Sclerosis.

• Authors : Wei J; Moon J; Yasumizu Y

• Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 09. Date of Electronic Publication: 2024 Feb 09.Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not

Record details

A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.

• Authors : Daboul L; Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/diagnostic imaging ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/pathology; Adult

• Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Jan; Vol. 30 (1), pp. 25-34. Date of Electronic Publication: 2023 Dec 13.Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.

• Authors : Anderson A; UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.; Rowles W

Subjects: Antineoplastic Agents* ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy; Pregnancy

• Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Nov; Vol. 10 (11), pp. 2053-2064. Date of Electronic Publication: 2023 Sep 07.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

Record details

Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.

• Authors : Alvarez E; The Rocky Mountain MS Center at the University of Colorado Anschutz Medical Campus, Academic Office 1 Building, Room 5512, 12631 East 17th Avenue, B185, Aurora, CO 80045, United States.; Longbrake EE

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/complications ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/chemically induced

• Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Nov; Vol. 79, pp. 105009. Date of Electronic Publication: 2023 Sep 15.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Gut Microbiome Wellness Index 2 for Enhanced Health Status Prediction from Gut Microbiome Taxonomic Profiles.

• Authors : Chang D; Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN 55455, USA.; Gupta VK

• Source: BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 02. Date of Electronic Publication: 2023 Oct 02.Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not

Record details